Insmed Inc Stock Fundamentals

INSM Stock  USD 27.15  1.09  3.86%   
Insmed Inc fundamentals help investors to digest information that contributes to Insmed's financial success or failures. It also enables traders to predict the movement of Insmed Stock. The fundamental analysis module provides a way to measure Insmed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Insmed stock.
At this time, Insmed's Gross Profit is very stable as compared to the past year. As of the 23rd of February 2024, Operating Expenses is likely to grow to about 803.5 M, while Consolidated Income is likely to drop (444.8 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Insmed Operating Margin Analysis

Insmed's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
 2021 2022 2023 2024 (projected)
Interest Expense40.5M26.4M30.4M25.7M
Gross Profit144.3M190.2M218.8M236.0M

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Insmed Operating Margin

    
  (1.75) %  
Most of Insmed's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insmed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Insmed EBITDA Margin

EBITDA Margin

(2.18)

At this time, Insmed's EBITDA Margin is very stable as compared to the past year.
Based on the recorded statements, Insmed Inc has an Operating Margin of -1.7537%. This is 95.0% lower than that of the Biotechnology sector and 98.44% lower than that of the Health Care industry. The operating margin for all United States stocks is 68.17% lower than that of the firm.

Insmed Inc Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Insmed's current stock value. Our valuation model uses many indicators to compare Insmed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insmed competition to find correlations between indicators driving Insmed's intrinsic value. More Info.
Insmed Inc is currently regarded as number one stock in retained earnings category among related companies. It is currently regarded as number one stock in price to sales category among related companies . As of the 23rd of February 2024, Price to Sales Ratio is likely to grow to 9.26. Comparative valuation analysis is a catch-all model that can be used if you cannot value Insmed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insmed's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Insmed's earnings, one of the primary drivers of an investment's value.

Insmed Market Capitalization Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insmed's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insmed could also be used in its relative valuation, which is a method of valuing Insmed by comparing valuation metrics of similar companies.
Insmed is currently under evaluation in market capitalization category among related companies.

Insmed Current Valuation Drivers

We derive many important indicators used in calculating different scores of Insmed from analyzing Insmed's financial statements. These drivers represent accounts that assess Insmed's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Insmed's important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Net Income Per Employee(584.7K)(562.9K)(709.1K)(654.3K)(588.8K)(635.3K)
Revenue Per Employee313.7K314.7K307.4K333.4K300.0K250.7K
Average Assets726.0M799.7M1.1B1.2B1.4B1.5B
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(205.9M)(243.0M)(369.2M)(431.4M)(388.3M)(398.5M)
Earnings Before Interest Taxes and Depreciation Amortization USD(205.9M)(243.0M)(369.2M)(431.4M)(388.3M)(398.5M)
Earnings before Tax(253.6M)(292.7M)(436.4M)(480.2M)(432.1M)(443.5M)
Average Equity266.6M311.2M412.0M55.5M63.9M65.5M
Enterprise Value2.0B3.2B3.0B3.1B3.6B2.9B
Free Cash Flow(292.9M)(225.6M)(370.6M)(410.3M)(369.3M)(379.0M)
Invested Capital513.0M500.2M793.9M1.5B1.7B1.9B
Invested Capital Average448.3M513.2M711.5M1.2B1.4B1.5B
Market Capitalization2.1B3.4B3.2B2.7B3.1B2.7B
Tangible Asset Value688.6M746.9M1.0B1.5B1.7B1.8B
Working Capital470.0M504.1M701.9M1.1B1.2B1.3B

Insmed Fundamentals

About Insmed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Insmed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insmed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Cost of Revenue63.4 M52.6 M
Revenues282.2 M304.4 M
Revenue to Assets 0.13  0.11 
Revenue Per Employee300 K250.7 K

Insmed Investors Sentiment

The influence of Insmed's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Insmed. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Insmed's public news can be used to forecast risks associated with an investment in Insmed. The trend in average sentiment can be used to explain how an investor holding Insmed can time the market purely based on public headlines and social activities around Insmed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Insmed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Insmed's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Insmed's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Insmed.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Insmed in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Insmed's short interest history, or implied volatility extrapolated from Insmed options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Insmed Piotroski F Score and Insmed Altman Z Score analysis.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.29)
Revenue Per Share
2.043
Quarterly Revenue Growth
0.167
Return On Assets
(0.36)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.